Peter Mac has been named Australia's leading #cancer research institute in The Australian newspaper's Research 2025 Magazine, and four of our researchers were named as leader in their field.
Read more: www.petermac.org/about-us/new...
@thomasbchadwick.bsky.social
PhD candidate at @petermaccc.bsky.social & UniMelb π¦πΊ | Studying IFN signalling in breast cancer metastasis π¦΄π§¬ | Member of the Parker Lab | Kings College London alum |π¬π
Peter Mac has been named Australia's leading #cancer research institute in The Australian newspaper's Research 2025 Magazine, and four of our researchers were named as leader in their field.
Read more: www.petermac.org/about-us/new...
The hallmarks of cancer immune evasion
www.cell.com/cancer-cell/...
Just sharing to my new BlueSky followers the review we published a couple of months ago. I think it summarises the topics we look at in our lab well and highlights the complexity of immune evasion in the metastatic cascade
π¦΄π§ π«π§¬
β‘οΈ www.nature.com/articles/s41...
Peter Mac is excited to join BlueSky! π¦ We look forward to sharing ideas, fostering positivity, and connecting with you all as we work together to advance cancer care and research. Letβs inspire, collaborate, and make a difference!
21.11.2024 00:23 β π 48 π 10 π¬ 3 π 0For ECRs going to Lorne Cancer 2025 - Rego & abstract submission is now open for the 2025 OzMRS ECR Symposium on Feb 12 - Join us for a day of extraordinary metastasis research!
Talks, flash talks and poster presentations are available. Abstract deadline is Dec 6. www.ozmrs.com/2025-ecr-sym...